An inexpensive malaria drug could be the answer for some women who are not responding to their cancer treatment, according to a promising but preliminary animal study. In a recent study published in Clinical Cancer Research, researchers discovered the anti-malaria drug hydroxychloroquine (HCQ) can actually reverse drug resistance to the common breast cancer drug, tamoxifen.

READ FULL ARTICLE Curated publisher From Time